This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Do Options Traders Know Something About Ingevity (NGVT) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Ingevity (NGVT) stock based on the movements in the options market lately.
Why Is Ingevity (NGVT) Down 26.3% Since Last Earnings Report?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ingevity's (NGVT) Earnings and Revenues Lag Estimates in Q1
by Zacks Equity Research
A slower recovery in automotive in China and continued destocking weigh on Ingevity's (NGVT) Q1 results.
Ingevity (NGVT) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of -13.49% and 4.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Green Plains Renewable Energy (GPRE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Green Plains (GPRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Ingevity (NGVT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why You Should Keep Ingevity (NGVT) Stock in Your Portfolio
by Zacks Equity Research
Ingevity (NGVT) gains on solid demand and higher selling prices in its Performance Chemicals segment, actions to drive long-term growth and price hike measures to mitigate cost inflation.
Ingevity (NGVT) Benefits From Strong Demand and Growth Actions
by Zacks Equity Research
Ingevity (NGVT) gains on strength in its engineered polymers and industrial specialties businesses and actions to drive growth amid costs-related headwinds.
Ingevity (NGVT) Down 16.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ingevity (NGVT) to Feature Capa at European Coatings Show
by Zacks Equity Research
Ingevity (NGVT) will showcase the benefits of using Capa technology and AltaVeg FA 120 at the European Coatings Show 2023.
Ingevity's (NGVT) Earnings and Revenues Miss Estimates in Q4
by Zacks Equity Research
Ingevity (NGVT) gains from higher pricing across its business amid headwinds from higher levels of consumer destocking weighing on its performance in Q4.
Ingevity (NGVT) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of -36.67% and 0.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axalta Coating Systems (AXTA) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 5.56% and 1.65%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT) Gains on Demand Strength and Growth Actions
by Zacks Equity Research
Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth amid costs-related headwinds.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Ingevity (NGVT) Up 9.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Industry Outlook Highlights Ashland, Livent, Ingevity and Flexible Solutions International
by Zacks Equity Research
Ashland, Livent, Ingevity and Flexible Solutions International are part of the Zacks Industry Outlook article.
4 Chemical Specialty Stocks to Escape Industry Challenges
by Anindya Barman
Slowing end-market demand and input cost pressure dampen prospects for the Zacks Chemicals Specialty industry. ASH, LTHM, NGVT and FSI are set to gain from self-help actions.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Basic Materials Stocks Lagging Glencore (GLNCY) This Year?
by Zacks Equity Research
Here is how Glencore PLC (GLNCY) and Ingevity (NGVT) have performed compared to their sector so far this year.
Ingevity's (NGVT) Earnings and Sales Top Estimates in Q3
by Zacks Equity Research
Ingevity (NGVT) benefits from strong demand and actions to increase prices in the third quarter.
How Much Upside is Left in Ingevity (NGVT)? Wall Street Analysts Think 30%
by Zacks Equity Research
The mean of analysts' price targets for Ingevity (NGVT) points to a 30% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Ingevity (NGVT) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 21.51% and 12.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?